| Literature DB >> 24223715 |
Veerajalandhar Allareddy1, Veerasathpurush Allareddy, Romesh P Nalliah, Sankeerth Rampa, Min Kyeong Lee.
Abstract
OBJECTIVE: To examine the prevalence and predictors of infection related never events (NE) associated with spinal fusion procedures (SFP) in children (age < = 18 years) in the United States.Entities:
Mesh:
Year: 2013 PMID: 24223715 PMCID: PMC3818374 DOI: 10.1371/journal.pone.0077540
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of Hospitalizations Undergoing Spinal Fusion Procedures.
| Characteristic | Frequency (%) [Total N = 56465] |
|
| |
| Male | 21560 (38.3%) |
| Female | 34746 (61.7%) |
| Missing | 159 |
|
| |
| Emergency/Urgent | 10101 (17.9%) |
| Elective | 46199 (82.1%) |
| Missing | 165 |
|
| |
| Medicare | 107 (0.2%) |
| Medicaid | 14183 (25.2%) |
| Private Insurance | 37960 (67.4%) |
| Uninsured | 1089 (1.9%) |
| Other insurance plans | 3007 (5.3%) |
| Missing | 119 |
|
| |
| White | 25278 (66.8%) |
| Black | 4753 (12.6%) |
| Hispanic | 4689 (12.4%) |
| Asian/Pacific Islander | 903 (2.4%) |
| Native American | 307 (0.8%) |
| Other Races | 1904 (5%) |
| Missing Information | 18630 |
|
| |
| Non-teaching | 6848 (12.1%) |
| Teaching | 49617 (87.9%) |
|
| |
| Small | 10289 (18.2%) |
| Medium | 13039 (23.1%) |
| Large | 33138 (58.7%) |
|
| |
| Northeast | 12099 (21.4%) |
| Midwest | 13580 (24%) |
| South | 20117 (35.6%) |
| West | 10668 (18.9%) |
|
| 13.7 |
The percentages may not add up to 100% because of rounding to nearest single digit decimal place.
Types of Spinal Fusions Performed During Hospitalization.
| Type of Spinal Fusion (ICD-9-CM Procedure Code) | Frequency (%) |
| Spinal fusion, not otherwise specified (81.00) | 443 (0.8%) |
| Atlas-axis spinal fusion (81.01) | 1343 (2.4%) |
| Other cervical fusion, anterior technique (81.02) | 2681 (4.7%) |
| Other cervical fusion, posterior technique (81.03) | 2709 (4.8%) |
| Dorsal and dorsolumbar fusion, anterior technique (81.04) | 6338(11.2%) |
| Dorsal and dorsolumbar fusion, posterior technique (81.05) | 38099 (67.5%) |
| Lumbar and lumbosacral fusion, anterior technique (81.06) | 1582 (2.8%) |
| Lumbar and lumbosacral fusion, lateral transverse process technique (81.07) | 313 (0.5%) |
| Lumbar and lumbosacral fusion, posterior technique (81.08) | 9395(16.6%) |
| Refusion of spine, not otherwise specified (81.30) | 34 (0.06%) |
| Refusion of atlas-axis spine (81.31) | 69 (0.1%) |
| Refusion of other cervical spine, anterior technique (81.32) | 34 (0.06%) |
| Refusion of other cervical spine, posterior technique (81.33) | 114 (0.2%) |
| Refusion of dorsal and dorsolumbar spine, anterior technique (81.34) | 142 (0.2%) |
| Refusion of dorsal and dorsolumbar spine, posterior technique (81.35) | 1150 (2%) |
| Refusion of lumbar and lumbosacral spine, anterior technique (81.36) | 88 (0.1%) |
| Refusion of lumbar and lumbosacral spine, lateral transverse process technique (81.37) | 18 (0.03%) |
| Refusion of lumbar and lumbosacral spine, posterior technique (81.38) | 618 (1.1%) |
| Refusion of spine, not elsewhere classified (81.39) | 81 (0.1%) |
The total numbers will not add to 56465 since any hospitalization might have underwent multiple spinal fusion procedures.
Frequently Reported Primary Diagnosis.
| Primary Diagnosis (Clinical Classification Software Code) | Frequency (%) |
| Bone disease and musculoskeletal deformities (212) | 29510 (52.3%) |
| Other acquired deformities (209) | 7567 (13.4%) |
| Other congenital anomalies (217) | 5888 (10.4%) |
| Other fractures (231) | 3549 (6.3%) |
| Spinal cord injury (227) | 2638 (4.7%) |
| Spondylosis; intervertebral disc disorders; other back problems (205) | 1518 (2.7%) |
| Complication of device; implant or graft (237) | 1437 (2.5%) |
| Other nervous system disorders (95) | 1044 (1.8%) |
| All other conditions | 3314 (5.9%) |
Presence of Co-Morbid Conditions.
| Co-morbid Condition | All Hospitals |
| AIDS | DS |
| Alcohol abuse | 261(0.5%) |
| Deficiency anemia’s | 4025 (7.1%) |
| Rheumatoid arthritis/collagen vascular diseases | 122 (0.2%) |
| Chronic blood loss anemia | 444(0.8%) |
| Congestive heart failure | 51 (0.1%) |
| Chronic pulmonary disease | 5500 (9.7%) |
| Coagulopathy | 1504 (2.7%) |
| Depression | 867 (1.5%) |
| Diabetes, uncomplicated | 184 (0.3%) |
| Diabetes with chronic complications | DS |
| Drug abuse | 349 (0.6%) |
| Hypertension | 790 (1.4%) |
| Hypothyroidism | 387 (0.7%) |
| Liver disease | 40 (0.07%) |
| Lymphoma | DS |
| Fluid and electrolyte disorders | 4286 (7.6%) |
| Metastatic cancer | 60 (0.1%) |
| Neurological disorders | 4201 (7.4%) |
| Obesity | 939 (1.7%) |
| Paralysis | 6165 (10.9%) |
| Peripheral vascular disorders | 111 (0.2%) |
| Psychoses | 413 (0.7%) |
| Pulmonary circulation disorders | 62 (0.1%) |
| Renal failure | 78 (0.1%) |
| Solid tumor without metastasis | 127 (0.2%) |
| Peptic ulcer disease excluding bleeding | DS |
| Valvular disease | 810 (1.4%) |
| Weight loss | 405 (0.7%) |
DS: discharge information suppressed as per data user agreement with AHRQ.
Prevalence of Never Events.
| Never Event (ICD-9-CM Diagnosis Code) | All Hospitalizations |
| Post-operative Pneumonia (481, 482, 485, 486, 507) | 1625 (2.9%) |
| Decubitus Ulcers (707) | 555 (1%) |
| Post-operative infections (998.59) | 475 (0.8%) |
| Infection with microorganisms resistant to penicillin (V09.0) | 120 (0.2%) |
|
| 171 (0.3%) |
| Infection and inflammatory reaction due to vascular device, implant, or graft (996.62) | 159 (0.3%) |
| Infection and inflammatory reaction due to indwelling urinary catheter (999.64) | 25 (0.04%) |
| Any One of the Above Event | 2720 (4.8%) |
DS: discharge information suppressed as per data user agreement with AHRQ.
Predictors of Never Events.
| Characteristic | Odds Ratio (95% CI) | p-value |
|
| 0.97 (0.94–1.00) | 0.02 |
|
| ||
| Female | 0.78 (0.65–0.94) | 0.008 |
| Male | Reference | |
|
| ||
| Elective | 0.66 (0.46–0.95) | 0.02 |
| Emergency/Urgent | Reference | |
|
| ||
| Medicare | - | - |
| Medicaid | 1.46 (1.17–1.83) | 0.0008 |
| Other insurance | 0.77 (0.46–1.29) | 0.32 |
| Uninsured | 0.96 (0.52–1.78) | 0.91 |
| Private insurance | Reference | |
|
| ||
| Black | 1.00 (0.71–1.40) | 0.98 |
| Hispanic | 1.27 (0.89–1.80) | 0.19 |
| Asian/Pacific Islander | 0.90 (0.35–2.26) | 0.82 |
| Native American | 0.71 (0.30–1.68) | 0.43 |
| Other Races | 0.77 (0.35–1.71) | 0.52 |
| Missing Information | 0.85 (0.66–1.10) | 0.22 |
| White | Reference | |
|
| ||
| Other acquired deformities | 1.82 (1.24–2.67) | 0.002 |
| Other congenital anomalies | 1.17 (0.76–1.81) | 0.46 |
| Other fractures | 1.25 (0.72–2.17) | 0.42 |
| Spinal cord injury | 6.94 (4.37–11.01) | <0.0001 |
| Spondylosis; intervertebral disc disorders; other back problems | 0.92 (0.39–2.20) | 0.85 |
| Complication of device; implant or graft | 1.51 (0.76–3.03) | 0.24 |
| Other nervous system disorders | 2.84 (1.68–4.79) | 0.0001 |
| Other conditions | 4.22 (3.06–5.84) | <0.0001 |
| Other bone disease and musculoskeletal deformities | Reference | |
|
| ||
| Alcohol abuse | 0.80 (0.31–2.07) | 0.65 |
| Deficiency anemia’s | 1.21 (0.85–1.74) | 0.29 |
| Rheumatoid arthritis/collagen vascular diseases | 0.58 (0.07–4.84) | 0.62 |
| Chronic blood loss anemia | 2.57 (1.17–5.66) | 0.02 |
| Congestive heart failure | 1.48 (0.18–12.42) | 0.72 |
| Chronic pulmonary disease | 1.16 (0.87–1.56) | 0.31 |
| Coagulopathy | 1.97 (1.31–2.97) | 0.001 |
| Depression | 2.00 (1.14–3.52) | 0.01 |
| Diabetes, uncomplicated | 2.65 (0.79–8.87) | 0.11 |
| Drug abuse | 3.71 (1.72–8.00) | 0.001 |
| Hypertension | 1.34 (0.75–2.41) | 0.32 |
| Hypothyroidism | 1.67 (0.66–4.20) | 0.28 |
| Liver disease | 5.00 (0.88–28.34) | 0.07 |
| Fluid and electrolyte disorders | 2.62 (2.04–3.37) | <0.0001 |
| Metastatic cancer | 0.00 | |
| Neurological disorders | 1.72 (1.23–2.41) | 0.002 |
| Obesity | 0.63 (0.28–1.39) | 0.25 |
| Paralysis | 1.75 (1.32–2.33) | 0.0001 |
| Peripheral vascular disorders | 1.50 (0.28–8.22) | 0.64 |
| Psychoses | 1.42 (0.71–2.83) | 0.32 |
| Pulmonary circulation disorders | 4.03 (0.87–18.59) | 0.07 |
| Renal failure | 5.45 (1.57–18.84) | 0.007 |
| Solid tumor without metastasis | 0.72 (0.09–5.88) | 0.76 |
| Valvular disease | 1.14 (0.53–2.44) | 0.73 |
| Weight loss | 4.61 (2.48–8.57) | <0.0001 |
|
| ||
| Northeast | 1.17 (0.86–1.57) | 0.32 |
| Midwest | 0.88 (0.65–1.20) | 0.42 |
| South | 1.04 (0.79–1.38) | 0.76 |
| West | Reference | |
|
| ||
| Teaching | 1.13 (0.83–1.54) | 0.43 |
| Non-teaching | Reference | |
|
| ||
| Large bed | 1.17 (0.93–1.46) | 0.17 |
| Small/Medium bed | Reference | |
|
| ||
| 2004 | 1.21 (0.87–1.70) | 0.26 |
| 2005 | 1.58 (1.15–2.18) | 0.005 |
| 2006 | 1.41 (1.00–1.99) | 0.047 |
| 2007 | 0.90 (0.65–1.24) | 0.51 |
| 2008 | Reference |